Literature DB >> 20434133

No effect of a common allelic variant in the reelin gene on intermediate phenotype measures of brain structure, brain function, and gene expression.

Heike Tost1, Barbara K Lipska, Radhakrishna Vakkalanka, Herve Lemaitre, Joseph H Callicott, Venkata S Mattay, Joel E Kleinman, Stefano Marenco, Daniel R Weinberger.   

Abstract

BACKGROUND: A recent genome-wide association study linked a common variant in RELN (rs7341475G) with risk for schizophrenia in women. In the largest neuroimaging intermediate phenotype study reported so far, we evaluated the effect of rs7341475 on an extended array of different neuroscientific measures.
METHODS: Brain structure was evaluated with voxel-based morphometry and diffusion tensor imaging. Brain function during working memory was examined with functional magnetic resonance imaging. The RELN expression was determined in postmortem brain tissue of the dorsolateral prefrontal cortex and hippocampus. A total of 736 datasets were examined (voxel-based morphometry: n = 230, diffusion tensor imaging: n = 93, functional magnetic resonance imaging: n = 308, RELN expression: n = 105).
RESULTS: Our analyses did not provide evidence for a significant main effect of gene or gene x sex interaction effect on any of the examined measures.
CONCLUSIONS: This study does not suggest a significant impact of rs7341475 on brain structure, function, and RELN expression, arguing that this single nucleotide polymorphism and others linked with it do not affect brain measures related to the biology of schizophrenia. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20434133      PMCID: PMC2900542          DOI: 10.1016/j.biopsych.2010.02.023

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  20 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  Reelin promoter hypermethylation in schizophrenia.

Authors:  Dennis R Grayson; Xiaomei Jia; Ying Chen; Rajiv P Sharma; Colin P Mitchell; Alessandro Guidotti; Erminio Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-16       Impact factor: 11.205

3.  Population-based and family-based association study of 5'UTR polymorphism of the reelin gene and schizophrenia.

Authors:  Céline Goldberger; David Gourion; Sophie Leroy; Franck Schürhoff; Marie-Chantal Bourdel; Marion Leboyer; Marie-Odile Krebs
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-08-05       Impact factor: 3.568

Review 4.  The endophenotype concept in psychiatry: etymology and strategic intentions.

Authors:  Irving I Gottesman; Todd D Gould
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

5.  Relative risk of attention deficits in siblings of patients with schizophrenia.

Authors:  M F Egan; T E Goldberg; T Gscheidle; M Weirich; L B Bigelow; D R Weinberger
Journal:  Am J Psychiatry       Date:  2000-08       Impact factor: 18.112

Review 6.  Reelin glycoprotein: structure, biology and roles in health and disease.

Authors:  S H Fatemi
Journal:  Mol Psychiatry       Date:  2005-03       Impact factor: 15.992

7.  Neural mechanisms of a genome-wide supported psychosis variant.

Authors:  Christine Esslinger; Henrik Walter; Peter Kirsch; Susanne Erk; Knut Schnell; Claudia Arnold; Leila Haddad; Daniela Mier; Carola Opitz von Boberfeld; Kyeon Raab; Stephanie H Witt; Marcella Rietschel; Sven Cichon; Andreas Meyer-Lindenberg
Journal:  Science       Date:  2009-05-01       Impact factor: 47.728

8.  Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down.

Authors:  Joseph H Callicott; Venkata S Mattay; Beth A Verchinski; Stefano Marenco; Michael F Egan; Daniel R Weinberger
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

9.  Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs.

Authors:  Barbara K Lipska; Tricia Peters; Thomas M Hyde; Nader Halim; Cara Horowitz; Shruti Mitkus; Cynthia Shannon Weickert; Mitsuyuki Matsumoto; Akira Sawa; Richard E Straub; Radhakrishna Vakkalanka; Mary M Herman; Daniel R Weinberger; Joel E Kleinman
Journal:  Hum Mol Genet       Date:  2006-03-01       Impact factor: 6.150

10.  A decrease of reelin expression as a putative vulnerability factor in schizophrenia.

Authors:  F Impagnatiello; A R Guidotti; C Pesold; Y Dwivedi; H Caruncho; M G Pisu; D P Uzunov; N R Smalheiser; J M Davis; G N Pandey; G D Pappas; P Tueting; R P Sharma; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

View more
  10 in total

1.  Partial support for ZNF804A genotype-dependent alterations in prefrontal connectivity.

Authors:  Frieder M Paulus; Sören Krach; Johannes Bedenbender; Martin Pyka; Jens Sommer; Axel Krug; Susanne Knake; Markus M Nöthen; Stephanie H Witt; Marcella Rietschel; Tilo Kircher; Andreas Jansen
Journal:  Hum Brain Mapp       Date:  2011-10-31       Impact factor: 5.038

Review 2.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

Review 3.  Association Between REELIN Gene Polymorphisms (rs7341475 and rs262355) and Risk of Schizophrenia: an Updated Meta-analysis.

Authors:  Sadiatul Marzan; Md Abdul Aziz; Mohammad Safiqul Islam
Journal:  J Mol Neurosci       Date:  2020-09-05       Impact factor: 3.444

4.  RELN rs7341475 and schizophrenia risk: confusing, yet somehow intriguing.

Authors:  Heike Tost; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2011-03-01       Impact factor: 13.382

5.  Prenatal nutrition, epigenetics and schizophrenia risk: can we test causal effects?

Authors:  James B Kirkbride; Ezra Susser; Marija Kundakovic; Jacob K Kresovich; George Davey Smith; Caroline L Relton
Journal:  Epigenomics       Date:  2012-06       Impact factor: 4.778

Review 6.  The involvement of Reelin in neurodevelopmental disorders.

Authors:  Timothy D Folsom; S Hossein Fatemi
Journal:  Neuropharmacology       Date:  2012-09-07       Impact factor: 5.250

Review 7.  Genetic underpinnings of white matter 'connectivity': heritability, risk, and heterogeneity in schizophrenia.

Authors:  Aristotle N Voineskos
Journal:  Schizophr Res       Date:  2014-06-02       Impact factor: 4.939

8.  Overexpression of Reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder.

Authors:  Cátia M Teixeira; Eduardo D Martín; Ignasi Sahún; Nuria Masachs; Lluís Pujadas; André Corvelo; Carles Bosch; Daniela Rossi; Albert Martinez; Rafael Maldonado; Mara Dierssen; Eduardo Soriano
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

9.  The genetic variation of RELN expression in schizophrenia and bipolar disorder.

Authors:  Galit Ovadia; Sagiv Shifman
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

10.  Placental genomic risk scores and early neurodevelopmental outcomes.

Authors:  Gianluca Ursini; Giovanna Punzi; Benjamin W Langworthy; Qiang Chen; Kai Xia; Emil A Cornea; Barbara D Goldman; Martin A Styner; Rebecca C Knickmeyer; John H Gilmore; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 12.779

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.